Center for Weight Loss Surgery explains the differences between duodenal switch and gastric sleeve surgeries for weight loss.

Among patients eligible for metabolic and bariatric surgery (MBS), glucagon-like peptide-1 receptor agonist (GLP-1 RA) ...

The use of GLP 1s increased dramatically from 2018 to 2025 among patients eligible for metabolic and bariatric surgery in the US, whereas surgery rates declined notably.

Bariatric (weight-loss) surgery includes procedures like gastric sleeve, gastric bypass, and biliopancreatic diversion to help individuals with severe obesity (typically BMI, or with co-morbidities) ...

After years of success on Wegovy, an Oakland patient faces relapse as California cuts Medi-Cal coverage for chronic obesity ...

Surgeons from across West Africa gathered at Accra, Ghana for the region’s inaugural bariatric and metabolic surgery session, ...

From 2023, there was a decrease in use of metabolic and bariatric surgery, with stronger decline for sleeve gastrectomy.

Lower preoperative BMI and suboptimal 12-month weight loss are linked to rapid weight regain within 2 years after sleeve ...

Bariatric surgery uptake has decreased since the fourth quarter of 2022, coinciding with a rise in prescriptions of semaglutide and tirzepatide for adults with obesity, according to a research letter ...

Six firefighters once had to lift him into an ambulance. Kashif Jeremiah Rodney, 36, has since lost 320lbs without Ozempic.

A new study suggests bariatric surgery may offer stronger long-term heart protection than GLP-1 drugs like Ozempic and Mounjaro.

Among metabolic and bariatric surgery (MBS)-eligible patients in a national sample, semaglutide and tirzepatide prescriptions ...